Tech Company Financing Transactions

Harbour BioMed Funding Round

Hudson Bay Capital, Country Garden and Greater Bay Area Investments invested in a $102.8 million Series C funding round for Harbour BioMed. The funding round was announced on 7/10/2020.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1 Bdwy. 14th Floor
Cambridge, MA 02142
USA

Phone

617-682-3679

Website

www.harbourbiomed.com

Email Address

[email protected]

Overview

Harbour BioMed is a global biotechnology company discovering and developing innovative therapeutics for cancer with a focus on immuno-oncology. The company's discovery and development programs are centered around its two patented transgenic mouse platforms for human antibody discovery.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jingsong Wang

        

VP - Bus. Development

Xiaoxiang Chen

        

VP - Bus. Development

Atul Deshpande

        

VP - Bus. Development

Mai-Jing Liao

        

VP - Engineering

Louis Liu

        

Browse more venture capital transactions:

Prev: 7/10/2020: SensorUp venture capital transaction
Next: 7/10/2020: Unum Therapeutics venture capital transaction

Share this article

News on VC Transactions

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary